Questions we get about HCC.

Phase 1 — pre-launch. The HCC token is registered on the Conceptual Chain with a 21B max supply. The mint mechanic (researcher contract → sealed-enclave query → HCC distribution to participating wallets) is implemented and tested in staging. No real researcher contract has been signed yet. Phase 2 begins when the first contract is countersigned, the first cohort query runs, and the first HCC mint event lands on chain. Until then, the chain shows zero HCC mint events on the data lane.

No. The mechanism is structured so researcher contracts purchase access to query a cohort inside a sealed enclave. Raw records never leave Datavault. The researcher receives aggregated results; you receive HCC. The closest analogy is a library license, not a sale.

The architecture is designed so that they cannot from anything they receive. Cohort queries with effective n < 200 are blocked at the enclave layer. Differential-privacy noise is applied to small cohorts. Wallet addresses on chain are pseudonymous and not linked to legal identity in any chain transaction. The mapping lives only in Datavault, which never publishes it.

Phase 2 attestation: independent re-identification audits will run quarterly once contracts begin. We do not yet have a published number of "simulated attacks" because no audit has been performed yet — we will not claim one until a signed report exists. See attestations for the timeline.

Depends on how often your data is in eligible cohorts and how dense your record is. Once Phase 2 begins, a typical wallet with 3+ years of clinical history and broad consent classes might see HCC routed to it several times per year, totaling small fractions of a coin. Wallets with rare conditions or particularly long longitudinal histories may see higher density. We do not promise specific amounts. Until contracts begin, no HCC is being routed to any wallet.

Yes, at any time, at any granularity. Drop a class, narrow it, pause all participation. Effective within one block (~5 seconds). Past mints stay in your wallet — that transaction has already happened. Future contracts that would have included you skip you, with no party informed why.

HCR is the clinical-outcomes coin (mints when you improve a Master Equation axis with verified evidence). HCC is the data-economy coin (mints when a researcher purchases access to a cohort you're in). Same chain, different lanes. See side-by-side comparison.

No. HCC will float once liquidity exists on hc.exchange. Price will be set by exchange demand against HCR and USD pairs. We do not subsidize, buy back, or promise stability. Today, with no contracts having executed, there is no spot market price for HCC; price discovery starts at Phase 2.

Yes, on hc.exchange — once Phase 2 begins and you have HCC in your wallet. Most patients are expected to hold or convert; some accumulate. There are no lockups on patient HCC. (Researcher and institution wallets have separate compliance terms.)

No. Clinical care, billing, and treatment decisions are completely separate from HCC eligibility. Opting in or out does not affect what your provider sees, what you're charged, or what your insurance covers. Master Equation axis tracking continues regardless.

Because every cohort query is research. IRB review verifies the question is ethically sound and the methods are appropriate before the contract is even priced. The IRB ID is pinned on chain alongside the contract — anyone can look it up.

The enclave logs every query against every researcher account. Cross-cohort joins that bring effective n below the cohort floor are detected and flagged. Re-identification attempts are a contract violation; the consequence is permanent revocation of researcher credentials and a chain-recorded incident. Phase 2 launches the first independent re-identification audit cycle (see attestations for the schedule).

Today (Phase 1) governance authority is operator-signed by Conceptual Healthcare Corporation, since no live parameters need ratification yet. Phase 2 introduces a multi-party Trust Council with seats drawn from licensed healthcare institutions, regulated custodians, an academic ethics representative, a patient-advocacy seat, and a sovereign-health-authority observer. All decisions are logged on the governance log.

No. HCC is a commodity-class digital asset, the same posture as HCR. It is not registered as a security and is not marketed as an investment. Holding HCC does not confer ownership in Conceptual Healthcare Corporation. The mint is a receipt for participation in a research transaction; secondary trading is for liquidity, not capital formation.